279 related articles for article (PubMed ID: 22362744)
21. MicroRNA and transcription factor co-regulatory networks and subtype classification of seminoma and non-seminoma in testicular germ cell tumors.
Qin G; Mallik S; Mitra R; Li A; Jia P; Eischen CM; Zhao Z
Sci Rep; 2020 Jan; 10(1):852. PubMed ID: 31965022
[TBL] [Abstract][Full Text] [Related]
22. Downregulated miR-17, miR-29c, miR-92a and miR-214 may be related to BCL11B overexpression in T cell acute lymphoblastic leukemia.
He Z; Liao Z; Chen S; Li B; Yu Z; Luo G; Yang L; Zeng C; Li Y
Asia Pac J Clin Oncol; 2018 Oct; 14(5):e259-e265. PubMed ID: 29749698
[TBL] [Abstract][Full Text] [Related]
23. The Notch/Hes1 pathway sustains NF-κB activation through CYLD repression in T cell leukemia.
Espinosa L; Cathelin S; D'Altri T; Trimarchi T; Statnikov A; Guiu J; Rodilla V; Inglés-Esteve J; Nomdedeu J; Bellosillo B; Besses C; Abdel-Wahab O; Kucine N; Sun SC; Song G; Mullighan CC; Levine RL; Rajewsky K; Aifantis I; Bigas A
Cancer Cell; 2010 Sep; 18(3):268-81. PubMed ID: 20832754
[TBL] [Abstract][Full Text] [Related]
24. MicroRNA and transcription factor mediated regulatory network analysis reveals critical regulators and regulatory modules in myocardial infarction.
Zhang G; Shi H; Wang L; Zhou M; Wang Z; Liu X; Cheng L; Li W; Li X
PLoS One; 2015; 10(8):e0135339. PubMed ID: 26258537
[TBL] [Abstract][Full Text] [Related]
25. [Bioinformatics analysis of microRNA comprehensive regulatory network in B- cell acute lymphoblastic leukemia].
Zeng MN; Ma WL; Zheng WL
Zhonghua Xue Ye Xue Za Zhi; 2016 Jul; 37(7):585-90. PubMed ID: 27535859
[TBL] [Abstract][Full Text] [Related]
26. Cellular proteolytic modification of tumor-suppressor CYLD is critical for the initiation of human T-cell acute lymphoblastic leukemia.
Arora M; Kaul D; Varma N; Marwaha RK
Blood Cells Mol Dis; 2015 Jan; 54(1):132-8. PubMed ID: 25130432
[TBL] [Abstract][Full Text] [Related]
27. Reciprocal activation between STAT3 and miR-181b regulates the proliferation of esophageal cancer stem-like cells via the CYLD pathway.
Xu DD; Zhou PJ; Wang Y; Zhang L; Fu WY; Ruan BB; Xu HP; Hu CZ; Tian L; Qin JH; Wang S; Wang X; Li YC; Liu QY; Ren Z; Zhang R; Wang YF
Mol Cancer; 2016 May; 15(1):40. PubMed ID: 27189061
[TBL] [Abstract][Full Text] [Related]
28. Systems biology approach identifies key regulators and the interplay between miRNAs and transcription factors for pathological cardiac hypertrophy.
Recamonde-Mendoza M; Werhli AV; Biolo A
Gene; 2019 May; 698():157-169. PubMed ID: 30844478
[TBL] [Abstract][Full Text] [Related]
29. Investigating the Role of MicroRNA and Transcription Factor Co-regulatory Networks in Multiple Sclerosis Pathogenesis.
Nuzziello N; Vilardo L; Pelucchi P; Consiglio A; Liuni S; Trojano M; Liguori M
Int J Mol Sci; 2018 Nov; 19(11):. PubMed ID: 30463275
[TBL] [Abstract][Full Text] [Related]
30. MiR-454 prompts cell proliferation of human colorectal cancer cells by repressing CYLD expression.
Liang HL; Hu AP; Li SL; Xie JP; Ma QZ; Liu JY
Asian Pac J Cancer Prev; 2015; 16(6):2397-402. PubMed ID: 25824771
[TBL] [Abstract][Full Text] [Related]
31. miR-501 is upregulated in cervical cancer and promotes cell proliferation, migration and invasion by targeting CYLD.
Sanches JGP; Xu Y; Yabasin IB; Li M; Lu Y; Xiu X; Wang L; Mao L; Shen J; Wang B; Hou L; Ju J; Zhao J; Song B
Chem Biol Interact; 2018 Apr; 285():85-95. PubMed ID: 29477382
[TBL] [Abstract][Full Text] [Related]
32. Expression of CYLD and NF-kappaB in human cholesteatoma epithelium.
Byun JY; Yune TY; Lee JY; Yeo SG; Park MS
Mediators Inflamm; 2010; 2010():796315. PubMed ID: 20414373
[TBL] [Abstract][Full Text] [Related]
33. Clinical significance of CYLD downregulation in breast cancer.
Hayashi M; Jono H; Shinriki S; Nakamura T; Guo J; Sueta A; Tomiguchi M; Fujiwara S; Yamamoto-Ibusuki M; Murakami K; Yamashita S; Yamamoto Y; Li JD; Iwase H; Ando Y
Breast Cancer Res Treat; 2014 Feb; 143(3):447-57. PubMed ID: 24398777
[TBL] [Abstract][Full Text] [Related]
34. Osteoclastic miR-301-b knockout reduces ovariectomy (OVX)-induced bone loss by regulating CYDR/NF-κB signaling pathway.
Zhu J; Wang H; Liu H
Biochem Biophys Res Commun; 2020 Aug; 529(1):35-42. PubMed ID: 32560816
[TBL] [Abstract][Full Text] [Related]
35. miR-181d regulates human dendritic cell maturation through NF-κB pathway.
Su XW; Lu G; Leung CK; Liu Q; Li Y; Tsang KS; Zhao SD; Chan DTM; Kung HF; Poon WS
Cell Prolif; 2017 Oct; 50(5):. PubMed ID: 28731516
[TBL] [Abstract][Full Text] [Related]
36. Downregulation of LEF1 Impairs Myeloma Cell Growth Through Modulating CYLD/NF-κB Signaling.
Zhang G; Miao F; Liu K; Wu J; Xu J
Technol Cancer Res Treat; 2021; 20():15330338211034270. PubMed ID: 34269120
[TBL] [Abstract][Full Text] [Related]
37. Negative regulation of JNK signaling by the tumor suppressor CYLD.
Reiley W; Zhang M; Sun SC
J Biol Chem; 2004 Dec; 279(53):55161-7. PubMed ID: 15496400
[TBL] [Abstract][Full Text] [Related]
38. MicroRNA-301b promotes cell proliferation and apoptosis resistance in triple-negative breast cancer by targeting CYLD.
Song H; Li D; Wu T; Xie D; Hua K; Hu J; Deng X; Ji C; Deng Y; Fang L
BMB Rep; 2018 Nov; 51(11):602-607. PubMed ID: 30269739
[TBL] [Abstract][Full Text] [Related]
39. Loss of CYLD expression unleashes Wnt signaling in multiple myeloma and is associated with aggressive disease.
van Andel H; Kocemba KA; de Haan-Kramer A; Mellink CH; Piwowar M; Broijl A; van Duin M; Sonneveld P; Maurice MM; Kersten MJ; Spaargaren M; Pals ST
Oncogene; 2017 Apr; 36(15):2105-2115. PubMed ID: 27775078
[TBL] [Abstract][Full Text] [Related]
40. miR-2909-mediated regulation of KLF4: a novel molecular mechanism for differentiating between B-cell and T-cell pediatric acute lymphoblastic leukemias.
Malik D; Kaul D; Chauhan N; Marwaha RK
Mol Cancer; 2014 Jul; 13():175. PubMed ID: 25037230
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
